ArticleThoracic cancer2022

Pretreatment HDL-C and ApoA1 are predictive biomarkers of progression-free survival in patients with EGFR mutated advanced non-small cell lung cancer treated with TKI.

Juan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.